PRA Group Inc Dossier
Financial Snapshot
Revenue, profitability, returns, debt, and capital allocation
Revenue $1.3B+19.4% YoYTTM through 30 Jun 2026
Net Income -$265M-475.4% YoYTTM through 30 Jun 2026
Free Cash Flow -$37.8MTTM through 30 Jun 2026
Margins
| Current | |
|---|---|
| Operating Margin | 32.5% |
| Net Margin | -19.9% |
Returns
2.6%ROE
0.5%ROA
-5.6%ROIC
Balance Sheet Health
Debt / Equity3.54x
Net Debt$3.7B
Cash & Equivalents$132.4M
Quality Metrics
Piotroski F-Score3 / 9
FCF Margin-2.8%
Earnings-Beat Rate75.0%
Multi-Year Trend
RevenueFY2025: $1.2B
Diluted EPS-$6.71TTMFY2025: $-7.79
Dividend
No dividend
Capital Allocation
Capex Intensity0.5%
Segment Performance
| Segment | Revenue | YoY | Outlook |
|---|---|---|---|
| U.S. Business | View detailsThe company continues to focus on refining processes, reducing cycle times, and optimizing post-judgment activities in the U.S. platform. | ||
| European Business | View detailsStable portfolio supply is expected to remain in the region for 2025. |
Filing Detail Members
This section is available to registered members. Create a free account or sign in to unlock the full breakdown.